Fujifilm invests $1.2bn ramping up North Carolina facility
Japanese medtech and imaging giant Fujifilm announced an investment of $1.2bn in its large-scale cell culture as it expands its…
All articles by Joshua Silverwood
Joshua Silverwood
-
-
Regulatory changes in the US and UK to watch in 2024
Significant regulatory changes across numerous medical fields are coming in 2024 with pharmaceutical and medical device companies urged to be…
-
Pfizer’s multiple myeloma treatment secures conditional approval in EU
Pfizer’s Elrexfio for treating multiple myeloma has been granted conditional market approval from the European Commission (EC), following a Phase…
-
Bayer’s stock drops to new 18-year low after asundexian trial termination
Bayer’s stock price has plummeted to its lowest since 2005 after a clinical trial investigating the anti-coagulant drug asundexian was…
-
UK unveils £520m for life sciences as part of Autumn Statement 2023
The UK government has revealed its Autumn 2023 statement, introducing a raft of measures and investments including £520m ($652.9m) for…
-
UK launches medicines scheme with £400m earmarked for clinical trials
The UK Government has signed a deal with the Association of the British Pharmaceutical Industry (ABPI) in a bid to…
-
Victoria Atkins MP takes over UK’s department of Health and Social Care
The UK Prime Minister, Rishi Sunak, has confirmed that Victoria Atkins has been appointed Secretary of State for Health and…
-
Telix strikes deal to distribute cancer imaging agent in the Nordics
An Australian manufacturer of a prostate cancer imaging agent has struck a deal with Danish company Wiik Pharma to distribute…
-
Trial sponsors say CROs need to own their mistakes and take responsibility
Trial sponsors have said that they want contract research organisations (CRO) to take more responsibility and own their mistakes when…
-
Sponsors urged to compensate oncology patients and meet trial staff face-to-face
Sponsors are being urged to compensate participants in oncological clinical trials, as well as make in-person visits to contract research…